{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:19:53Z","timestamp":1788268793983,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The ongoing Orthoebolavirus bundibugyoense\u2014Bundibugyo virus (BDBV)\u2014epidemic is the worst Ebolavirus outbreak in a decade and is rapidly expanding, with &gt;4600 suspected cases in the Democratic Republic of Congo (DRC) alone. It has caused 2186 deaths and spread to neighboring countries. As BDBV has no approved vaccine, timely response will require adapted use of existing vaccines approved for other ebolaviruses and expedited development of novel vaccines targeted toward BDBV. Access to vaccines is fundamental to public health emergency response and generally depends on two expert bodies in each country: a national regulatory authority (e.g., the US Food and Drug Administration (FDA)) and a national immunization advisor. Receding traditional global health assistance compounds already-limited licensure and recommended use in the DRC and other low-income countries confronting recent outbreaks of Ebola, Marburg, and mpox, exacerbating access gaps for high-risk populations. This commentary thus clarifies the critical importance of a robust national immunization advisor, coordinated closely with expanded licensure, in expediting access to vaccines and other essential epidemic response tools. Using the regulatory responses of the Republic of Rwanda and DRC, it demonstrates that clearer delineation of roles between these bodies is critical for effective response, can help prioritize self-sufficiency and greater regional public health cooperation, and will thus enable swifter control of Bundibugyo.<\/jats:p>","DOI":"10.3390\/v18090957","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:41:18Z","timestamp":1788266478000},"page":"957","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aligning Licensure and Recommended Use to Expedite Vaccine Access in Response to the Ongoing Bundibugyo Ebolavirus Epidemic in Central Africa"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-624X","authenticated-orcid":false,"given":"George L.","family":"O\u2019Hara","sequence":"first","affiliation":[{"name":"O\u2019Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC 20001, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Halabi","sequence":"additional","affiliation":[{"name":"O\u2019Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC 20001, USA"},{"name":"Department of Health Management & Policy, School of Health, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2026). Ebola Bundibugyo Virus Disease Outbreak Democratic Republic of the Congo|Uganda Weekly External Situation Report 14, Data as of 16 August 2026, World Health Organization."},{"key":"ref_2","unstructured":"World Health Organization (2026). Ebola Disease Caused by Bundibugyo Virus\u2014Democratic Republic of the Congo, World Health Organization."},{"key":"ref_3","unstructured":"Geddes, L. (2026). The World\u2019s First Bundibugyo Ebola Vaccine Has Entered Human Trials: Here\u2019s Why It Matters, GAVI."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/d41586-026-02278-x","article-title":"First volunteer gets Ebola vaccine\u2014Three months after the outbreak began","volume":"656","author":"Shenai","year":"2026","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mire, C.E., Geisbert, J.B., Marzi, A., Agans, K.N., Feldmann, H., and Geisbert, T.W. (2013). Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus. PLoS Neglected Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002600"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMc2608018","article-title":"Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines","volume":"395","author":"Lhomme","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2014.12.068","article-title":"Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy","volume":"33","author":"Roberts","year":"2015","journal-title":"Vaccine"},{"key":"ref_8","unstructured":"World Health Organization (2016). Fractional Dose Yellow Fever Vaccine as a Dose-Sparing Option for Outbreak Response: WHO Secretariat Information Paper, World Health Organization."},{"key":"ref_9","unstructured":"World Health Organization (2016). Polio vaccines: WHO position paper\u2014March, 2016. Wkly. Epidemiol. Rec., 91, 145\u2013168."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s43441-022-00480-3","article-title":"Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries","volume":"57","author":"Franco","year":"2023","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41541-025-01224-8","article-title":"How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak","volume":"10","author":"Nsanzimana","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_12","unstructured":"Joi, P. (2026, May 26). Bundibugyo, the Rare Virus Causing a Deadly New Ebola Outbreak, Has No Vaccine Yet. Here\u2019s What We Know. Available online: https:\/\/www.gavi.org\/vaccineswork\/bundibugyo-rare-virus-causing-deadly-new-ebola-outbreak-drc-has-no-vaccine-yet."},{"key":"ref_13","unstructured":"(2026, July 15). Coalitions for Epidemic Preparedness Innovations. African Phase I Clinical Trial Units: Request for Information (RFI) Summary. Available online: https:\/\/cepi-tr.tghn.org\/priority-diseases\/filoviruses\/."},{"key":"ref_14","unstructured":"World Health Organization (2024). Senegal and Rwanda Achieve WHO Maturity Level 3 in Medicines Regulation, World Health Organization."},{"key":"ref_15","unstructured":"(2026, February 27). Japan Ministry of Health, Labour and Welfare, Quarantine Station. Mpox\u2014Democratic Republic of the Congo (Translated from Japanese). Available online: https:\/\/www.forth.go.jp\/topics\/2024\/20240719_00001.html."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/14760584.2024.2397006","article-title":"Vaccines against mpox: MVA-BN and LC16m8","volume":"23","author":"Grabenstein","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mbala-Kingebeni, P., Rimoin, A.W., Kacita, C., Liesenborghs, L., Nachega, J.B., and Kindrachuk, J. (2024). The time is now (again) for mpox containment and elimination in Democratic Republic of the Congo. PLoS Glob. Public Health, 4.","DOI":"10.1371\/journal.pgph.0003171"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1126\/science.adu8279","article-title":"\u2018I\u2019m Really Shocked.\u2019 Children Not Being Vaccinated for Mpox in Congo","volume":"386","author":"Cohen","year":"2024","journal-title":"Science"},{"key":"ref_19","unstructured":"World Health Organization (2022). Vaccines And Immunization for Monkeypox: Interim Guidance, 16 November 2022, World Health Organization."},{"key":"ref_20","unstructured":"World Health Organization (2024). WHO Prequalifies the First Vaccine Against Mpox, World Health Organization."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/heapol\/czac092","article-title":"Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: A scoping review","volume":"38","author":"Guillaume","year":"2023","journal-title":"Health Policy Plan."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1586\/erv.11.96","article-title":"Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups","volume":"10","author":"Chocarro","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMp2406390","article-title":"Preparing for the Next Pandemic\u2014Expanding and Coordinating Global Regulatory Capacity","volume":"391","author":"Halabi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"K\u00fclper-Schiek, W., Mosina, L., Jacques-Carroll, L.A., Falman, A., Harder, T., Kakarriqi, E., Preza, I., Badalyan, A., Sahakyan, G., and Romanova, O. (2025). Evaluation of National Immunization Technical Advisory Groups (NITAGs) of middle-income countries in the WHO European Region; a synopsis. Front. Public Health, 13.","DOI":"10.3389\/fpubh.2025.1464370"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.2026.0276","article-title":"Navigating Conflicting Vaccination Recommendations: Guidance for Clinicians","volume":"335","author":"Mello","year":"2026","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nishtar, S. (2026). Financial innovation can deliver a Bundibugyo Ebola vaccine. Nat. Health, Online First.","DOI":"10.1038\/s44360-026-00173-3"},{"key":"ref_27","unstructured":"China Global Television Network (2026). Africa CDC Urges Urgent Vaccine Deployment as Ebola Outbreak Spreads Across DR Congo, China Global Television Network."},{"key":"ref_28","first-page":"e53957","article-title":"The Rwandan Healthcare System: Can a Shifting Burden of Disease Threaten a Post-war Success Story?","volume":"16","author":"Emeli","year":"2024","journal-title":"Cureus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e70225","DOI":"10.1002\/puh2.70225","article-title":"Public Health Achievements in Rwanda: A 21st Century Transformation","volume":"5","author":"Julius","year":"2026","journal-title":"Public Health Chall."},{"key":"ref_30","unstructured":"Karan, A., Katz, I.T., and Jha, A.K. (2018). Ebola in the DRC Is More About the DRC than It Is About Ebola. Health Aff."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/957\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:44:29Z","timestamp":1788266669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["v18090957"],"URL":"https:\/\/doi.org\/10.3390\/v18090957","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}